Lack of Evidence Regarding Markers Identifying Acute Heart Failure in Patients with COPD: An AI-Supported Systematic Review

References

• World Health Organization. The top 10 causes of death; 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed August 17, 2023.
   Google Scholar
• GOLD comittee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2023 report); 2022.
   Google Scholar
• Pellicori P, Cleland JGF, Clark AL. Chronic obstructive pulmonary disease and heart failure: a breathless conspiracy. Heart Fail Clin. 2020;16(1):33–44. doi:10.1016/j.hfc.2019.08.003
   PubMed Web of Science ®Google Scholar
• MacDonald MI, Shafuddin E, King PT, Chang CL, Bardin PG, Hancox RJ. Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease. Lancet Respir Med. 2016;4(2):138–148. doi:10.1016/S2213-2600(15)00509-3
   PubMed Web of Science ®Google Scholar
• Krahnke JS, Abraham WT, Adamson PB, et al. Heart failure and respiratory hospitalizations are reduced in patients with heart failure and chronic obstructive pulmonary disease with the use of an implantable pulmonary artery pressure monitoring device. Physiol Behav. 2016;176(1):139–148. doi:10.1016/j.cardfail.2014.12.008.Heart
   Google Scholar
• van Dijk SHB, Brusse-Keizer MGJ, Effing T, et al. Exploring patterns of COPD exacerbations and comorbid flare-ups. Int J Chron Obstruct Pulmon Dis. 2023;18:2633–2644. doi:10.2147/COPD.S428960
   PubMed Web of Science ®Google Scholar
• Renier W, Hoogma-Von Winckelmann K, Verbakel JY, Aertgeerts B, Buntinx F. Signs and symptoms in adult patients with acute dyspnea: a systematic review and meta-analysis. Eur J Emerg Med. 2018;25(1):3–11. doi:10.1097/MEJ.0000000000000429
   PubMed Web of Science ®Google Scholar
• Hawkins NM, Virani S, Ceconi C. Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services. Eur Heart J. 2013;34(36):2795–2803. doi:10.1093/eurheartj/eht192
   PubMed Web of Science ®Google Scholar
• Hillas G, Perlikos F, Tsiligianni I, Tzanakis N. Managing comorbidities in COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:95–109. doi:10.2147/COPD.S54473
   PubMed Web of Science ®Google Scholar
• Axson EL, Bottle A, Cowie MR, Quint JK. Relationship between heart failure and the risk of acute exacerbation of COPD. Thorax. 2021;76(8):807–814. doi:10.1136/thoraxjnl-2020-216390
   PubMed Web of Science ®Google Scholar
• Metra M, Teerlink JR. Heart failure. Lancet. 2017;390(10106):1981–1995. doi:10.1016/S0140-6736(17)31071-1
   PubMed Web of Science ®Google Scholar
• McDonagh TA, Metra M, Adamo M, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726. doi:10.1093/eurheartj/ehab368
   PubMed Web of Science ®Google Scholar
• Pantazopoulos I, Magounaki K, Kotsiou O, et al. Incorporating biomarkers in copd management: the research keeps going. J Pers Med. 2022;12(3):379. doi:10.3390/jpm12030379
   PubMed Web of Science ®Google Scholar
• Hoult G, Gillespie D, Wilkinson TMA, Thomas M, Francis NA. Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis. BMC Pulm Med. 2022;22(1):1–16. doi:10.1186/s12890-022-01958-4
   PubMed Web of Science ®Google Scholar
• Aimo A, Vergaro G, Januzzi J, et al. Additive prognostic value of cardiac biomarkers in patients with chronic obstructive pulmonary disease and heart failure. Eur Heart J. 2021;42(Supplement_1):2021. doi:10.1093/eurheartj/ehab724.0987
   Google Scholar
• Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJV. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail. 2009;11(2):130–139. doi:10.1093/eurjhf/hfn013
   PubMed Web of Science ®Google Scholar
• Su X, Lei T, Yu H. NT-proBNP in different patient groups of copd: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2023;18:811–825. doi:10.2147/COPD.S396663
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. J Clin Epidemiol. 2021;134:178–189. doi:10.1016/j.jclinepi.2021.03.001
   PubMed Web of Science ®Google Scholar
• Covidence systematic review software. Melbourne, Australia: Veritas Health Foundation.
   Google Scholar
• McKeown S, Mir ZM. Considerations for conducting systematic reviews: evaluating the performance of different methods for de-duplicating references. Syst Rev. 2021;10(1):4–11. doi:10.1186/s13643-021-01583-y
   PubMed Web of Science ®Google Scholar
• van de Schoot R, de Bruin J, Schram R, et al. An open source machine learning framework for efficient and transparent systematic reviews. Nat Mach Intell. 2021;3(2):125–133. doi:10.1038/s42256-020-00287-7
   Google Scholar
• van Dijk SHB, Brusse-Keizer MGJ, Bucsán CC, van der Palen J, Doggen CJM, Lenferink A. Artificial intelligence in systematic reviews: promising when appropriately used. BMJ Open. 2023;13:e072254. doi:10.1136/bmjopen-2023-072254
   PubMed Web of Science ®Google Scholar
• Reitsma JB. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(4):529–536. doi:10.7326/0003-4819-155-8-201110180-00009
   PubMedGoogle Scholar
• McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012;22(3):276–282. doi:10.11613/BM.2012.031
   PubMed Web of Science ®Google Scholar
• Dieplinger B, Gegenhuber A, Haltmayer M, Mueller T. Evaluation of novel biomarkers for the diagnosis of acute destabilised heart failure in patients with shortness of breath. Heart. 2009;95(18):1508–1513. doi:10.1136/hrt.2009.170696
   PubMed Web of Science ®Google Scholar
• Dieplinger B, Gegenhuber A, Kaar G, Poelz W, Haltmayer M, Mueller T. Prognostic value of established and novel biomarkers in patients with shortness of breath attending an emergency department. Clin Biochem. 2010;43(9):714–719. doi:10.1016/j.clinbiochem.2010.02.002
   PubMed Web of Science ®Google Scholar
• Fabbian F, De Giorgi A, Pala M, Tiseo R, Portaluppi F. Elevated NT-proBNP levels should be interpreted in elderly patients presenting with dyspnea. Eur J Intern Med. 2011;22(1):108–111. doi:10.1016/j.ejim.2010.07.013
   PubMed Web of Science ®Google Scholar
• Gálvez-Barrón C, Villar-álvarez F, Ribas J, et al. Effort oxygen saturation and effort heart rate to detect exacerbations of chronic obstructive pulmonary disease or congestive heart failure. J Clin Med. 2019;8(1):42. doi:10.3390/jcm8010042
   PubMed Web of Science ®Google Scholar
• Høiseth AD, Brynildsen J, Hagve TA, et al. The influence of heart failure co-morbidity on high-sensitivity troponin T levels in COPD exacerbation in a prospective cohort study: data from the Akershus cardiac examination (ACE) 2 study. Biomarkers. 2016;21(2):173–179. doi:10.3109/1354750X.2015.1126645
   PubMed Web of Science ®Google Scholar
• Winther JA, Brynildsen J, Høiseth AD, et al. Prevalence and prognostic significance of hyponatremia in patients with acute exacerbation of chronic obstructive pulmonary disease: data from the akershus cardiac examination (ACE) 2 study. PLoS One. 2016;11(8):1–14. doi:10.1371/journal.pone.0161232
   Web of Science ®Google Scholar
• Winther JA, Brynildsen J, Høiseth AD, et al. Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 study. Respir Res. 2017;18(1):1–10. doi:10.1186/s12931-017-0665-z
   PubMedGoogle Scholar
• Pervez MO, Lyngbakken MN, Myhre PL, et al. Mid-regional pro-adrenomedullin in patients with acute dyspnea: data from the Akershus Cardiac Examination (ACE) 2 Study. Clin Biochem. 2017;50(7–8):394–400. doi:10.1016/j.clinbiochem.2016.12.010
   PubMed Web of Science ®Google Scholar
• Pervez MO, Winther JA, Brynildsen J, et al. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study. Biomarkers. 2018;23(7):654–663. doi:10.1080/1354750X.2018.1474258
   PubMed Web of Science ®Google Scholar
• Johannessen Ø, Uthaug Reite F, Bhatnagar R, Øvrebotten T, Einvik G, Myhre PL. Lung ultrasound to assess pulmonary congestion in patients with acute exacerbation of COPD. Int J Chron Obstruct Pulmon Dis. 2023;18(April):693–703. doi:10.2147/COPD.S396855
   PubMedGoogle Scholar
• McCullough PA, Hollander JE, Nowak RM, et al. Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad Emerg Med. 2003;10(3):198–204. doi:10.1197/aemj.10.3.198
   PubMed Web of Science ®Google Scholar
• Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of b-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161–167. doi:10.1056/nejmoa020233
   PubMed Web of Science ®Google Scholar
• Moon JY, Bae JH, Kim TH, et al. The role of plasma B-type natriuretic peptide measurements in the differential diagnosis of acute dyspnea. Tuberc Respir Dis. 2005;59(6):656–663. doi:10.4046/trd.2005.59.6.656
   Google Scholar
• Tinè M, Bazzan E, Semenzato U, et al. Heart failure is highly prevalent and difficult to diagnose in severe exacerbations of copd presenting to the emergency department. J Clin Med. 2020;9(8):1–12. doi:10.3390/jcm9082644
   Web of Science ®Google Scholar
• Tung RH, Camargo CA, Krauser D, et al. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease. Ann Emerg Med. 2006;48(1):66–74. doi:10.1016/j.annemergmed.2005.12.022
   PubMed Web of Science ®Google Scholar
• Yamanoğlu A, Çelebi Yamanoğlu NG, Parlak İ, et al. The role of inferior vena cava diameter in the differential diagnosis of dyspneic patients; best sonographic measurement method? Am J Emerg Med. 2015;33(3):396–401. doi:10.1016/j.ajem.2014.12.032
   PubMed Web of Science ®Google Scholar
• McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) multinational study. Circulation. 2002;106(4):416–422. doi:10.1161/01.CIR.0000025242.79963.4C
   PubMed Web of Science ®Google Scholar
• Pellicori P, Salekin D, Pan D, Clark AL. This patient is not breathing properly: is this COPD, heart failure, or neither? Expert Rev Cardiovasc Ther. 2017;15(5):389–396. doi:10.1080/14779072.2017.1317592
   PubMed Web of Science ®Google Scholar
• Nicolae B, Ecaterina L. Natriuretic peptides in elderly patients with chronic obstructive pulmonary disease. Egypt J Bronchol. 2022;16(1). doi:10.1186/s43168-022-00132-y
   Google Scholar
• Sin DD, Vestbo J. Biomarkers in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2009;6(6):543–545. doi:10.1513/pats.200904-019DS
   PubMedGoogle Scholar
• Malik AN, Rowland J, Haber BD, et al. The use of handheld ultrasound devices in emergency medicine. Curr Emerg Hosp Med Rep. 2021;9(3):73–81. doi:10.1007/s40138-021-00233-w
   PubMed Web of Science ®Google Scholar
• Wong CW, Tafuro J, Azam Z, et al. Misdiagnosis of heart failure: a systematic review of the literature. J Card Fail. 2021;27(9):925–933. doi:10.1016/j.cardfail.2021.05.014
   PubMed Web of Science ®Google Scholar
• Rutten FH, Cramer MJM, Grobbee DE, et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J. 2005;26(18):1887–1894. doi:10.1093/eurheartj/ehi291
   PubMed Web of Science ®Google Scholar
• Liu C, Liu A, Halabi S. A min-max combination of biomarkers to improve diagnostic accuracy. Stat Med. 2011;30(161):2005–2014. doi:10.1002/sim.4238
   PubMedGoogle Scholar
• Bossuyt PM, Reitsma JB, Bruns DE, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ. 2015;351:h5527.doi:10.1136/bmj.h5527
   PubMed Web of Science ®Google Scholar
• The Criteria Committee of the New York Heart Association; Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. Little, Brown & Co; 1994.
   Google Scholar